177 related articles for article (PubMed ID: 8323331)
1. Functional significance of dystrophin positive fibres in Duchenne muscular dystrophy.
Nicholson LV; Johnson MA; Bushby KM; Gardner-Medwin D
Arch Dis Child; 1993 May; 68(5):632-6. PubMed ID: 8323331
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy.
Nicholson LV; Johnson MA; Gardner-Medwin D; Bhattacharya S; Harris JB
Acta Neuropathol; 1990; 80(3):239-50. PubMed ID: 2205076
[TBL] [Abstract][Full Text] [Related]
3. The "rescue" of dystrophin synthesis in boys with Duchenne muscular dystrophy.
Nicholson LV
Neuromuscul Disord; 1993; 3(5-6):525-31. PubMed ID: 8186705
[TBL] [Abstract][Full Text] [Related]
4. Dystrophin in skeletal muscle. II. Immunoreactivity in patients with Xp21 muscular dystrophy.
Nicholson LV; Davison K; Johnson MA; Slater CR; Young C; Bhattacharya S; Gardner-Medwin D; Harris JB
J Neurol Sci; 1989 Dec; 94(1-3):137-46. PubMed ID: 2693618
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of dystrophin positive fibers in Duchenne muscular dystrophy].
Chuang YH; Jong YJ; Liu KM; Chen SS
Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 Jul; 11(7):409-15. PubMed ID: 7650780
[TBL] [Abstract][Full Text] [Related]
6. Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot.
Voit T; Stuettgen P; Cremer M; Goebel HH
Neuropediatrics; 1991 Aug; 22(3):152-62. PubMed ID: 1944822
[TBL] [Abstract][Full Text] [Related]
7. Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 3. Differential diagnosis and prognosis.
Nicholson LV; Johnson MA; Bushby KM; Gardner-Medwin D; Curtis A; Ginjaar IB; den Dunnen JT; Welch JL; Butler TJ; Bakker E
J Med Genet; 1993 Sep; 30(9):745-51. PubMed ID: 8411069
[TBL] [Abstract][Full Text] [Related]
8. Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groups.
Nicholson LV; Johnson MA; Bushby KM; Gardner-Medwin D; Curtis A; Ginjaar IB; den Dunnen JT; Welch JL; Butler TJ; Bakker E
J Med Genet; 1993 Sep; 30(9):728-36. PubMed ID: 8411067
[TBL] [Abstract][Full Text] [Related]
9. Dystrophin or a "related protein" in Duchenne muscular dystrophy?
Nicholson LV; Johnson MA; Davison K; O'Donnell E; Falkous G; Barron M; Harris JB
Acta Neurol Scand; 1992 Jul; 86(1):8-14. PubMed ID: 1519480
[TBL] [Abstract][Full Text] [Related]
10. Dystrophin immunostaining in muscles from patients with different types of muscular dystrophy: a Brazilian study.
Vainzof M; Pavanello RC; Pavanello Filho I; Passos-Bueno MR; Rapaport D; Hsi CT; Zatz M
J Neurol Sci; 1990 Sep; 98(2-3):221-33. PubMed ID: 1700808
[TBL] [Abstract][Full Text] [Related]
11. Localization and characterization of dystrophin in muscle biopsy specimens from Duchenne muscular dystrophy and various neuromuscular disorders.
Uchino M; Araki S; Miike T; Teramoto H; Nakamura T; Yasutake T
Muscle Nerve; 1989 Dec; 12(12):1009-16. PubMed ID: 2695839
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of Duchenne and Becker muscular dystrophy phenotypes with amino- and carboxy-terminal antisera specific for dystrophin.
Bulman DE; Murphy EG; Zubrzycka-Gaarn EE; Worton RG; Ray PN
Am J Hum Genet; 1991 Feb; 48(2):295-304. PubMed ID: 1990838
[TBL] [Abstract][Full Text] [Related]
13. The abnormal expression of utrophin in Duchenne and Becker muscular dystrophy is age related.
Taylor J; Muntoni F; Dubowitz V; Sewry CA
Neuropathol Appl Neurobiol; 1997 Oct; 23(5):399-405. PubMed ID: 9364465
[TBL] [Abstract][Full Text] [Related]
14. Is dystrophin labelling always discontinuous in Becker muscular dystrophy?
Slater CR; Nicholson LV
J Neurol Sci; 1991 Feb; 101(2):187-92. PubMed ID: 2033404
[TBL] [Abstract][Full Text] [Related]
15. Dystrophin abnormalities in Duchenne and Becker dystrophy carriers: correlation with cytoskeletal proteins and myosins.
Mora M; Morandi L; Piccinelli A; Gussoni E; Gebbia M; Blasevich F; Dworzak F; Cornelio F
J Neurol; 1993 Sep; 240(8):455-61. PubMed ID: 8263549
[TBL] [Abstract][Full Text] [Related]
16. A homologue of dystrophin is expressed at the blood vessel membrane of DMD and BMD patients: immunological evidence.
Augier N; Boucraut J; Léger J; Anoal M; Nicholson LV; Voelkel MA; Léger JJ; Pellissier JF
J Neurol Sci; 1992 Feb; 107(2):233-8. PubMed ID: 1564523
[TBL] [Abstract][Full Text] [Related]
17. Cardiac dystrophin abnormalities in Becker muscular dystrophy assessed by endomyocardial biopsy.
Maeda M; Nakao S; Miyazato H; Setoguchi M; Arima S; Higuchi I; Osame M; Taira A; Nomoto K; Toda H
Am Heart J; 1995 Apr; 129(4):702-7. PubMed ID: 7900621
[TBL] [Abstract][Full Text] [Related]
18. An unusual case of Duchenne muscular dystrophy.
Topaloğlu H; Dinçer P; Göğüş S; Ayter S; Topçu M
Brain Dev; 1993; 15(4):313-5. PubMed ID: 8250158
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of dystrophin in fetuses at risk for Duchenne muscular dystrophy.
Clerk A; Sewry CA; Dubowitz V; Strong PN
J Neurol Sci; 1992 Aug; 111(1):82-91. PubMed ID: 1403002
[TBL] [Abstract][Full Text] [Related]
20. [Specificity of the dystrophin immunohistochemical technique in muscular dystrophy].
Colomer Oferil J; Vila Torres J; Huezo Montoya C
Neurologia; 1993 May; 8(5):112-5. PubMed ID: 8507503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
